These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 22952803

  • 21. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
    Jeong JH, Jeong YJ, Cho HJ, Shin JM, Kang JH, Park KK, Park YY, Chung IK, Chang HW, Magae J.
    J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
    [Abstract] [Full Text] [Related]

  • 22. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H, Zhang S.
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [Abstract] [Full Text] [Related]

  • 23. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L, Xie J, Liu Z, Huang Z, Huang M, Yin H, Qi W, Yang Z, Zhou T, Gao G, Zhang J, Yang X.
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [Abstract] [Full Text] [Related]

  • 24. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.
    Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK, Wiedemann P.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1873-9. PubMed ID: 19098317
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL.
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α.
    Wang Y, Chen W, Lian J, Zhang H, Yu B, Zhang M, Wei F, Wu J, Jiang J, Jia Y, Mo F, Zhang S, Liang X, Mou X, Tang J.
    Cell Death Differ; 2020 Feb; 27(2):695-710. PubMed ID: 31320749
    [Abstract] [Full Text] [Related]

  • 29. Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells.
    Shin JM, Jeong YJ, Cho HJ, Park KK, Chung IK, Lee IK, Kwak JY, Chang HW, Kim CH, Moon SK, Kim WJ, Choi YH, Chang YC.
    PLoS One; 2013 Feb; 8(7):e69380. PubMed ID: 23936001
    [Abstract] [Full Text] [Related]

  • 30. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y, Xu Y, Ma J, Pang X, Dong M.
    Sci Rep; 2017 Jan 16; 7():40524. PubMed ID: 28091613
    [Abstract] [Full Text] [Related]

  • 31. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Huang J, Li HB, Yu S, Yuan F, Lou ZP.
    Eur Rev Med Pharmacol Sci; 2020 May 16; 24(9):4793-4802. PubMed ID: 32432742
    [Abstract] [Full Text] [Related]

  • 32. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.
    Shi YH, Wang YX, Bingle L, Gong LH, Heng WJ, Li Y, Fang WG.
    J Pathol; 2005 Mar 16; 205(4):530-6. PubMed ID: 15714461
    [Abstract] [Full Text] [Related]

  • 33. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
    Jinnouchi Y, Yamagishi S, Matsui T, Takenaka K, Yoshida Y, Nakamura K, Ueda S, Imaizumi T.
    Brain Res; 2007 Sep 05; 1167():92-100. PubMed ID: 17692294
    [Abstract] [Full Text] [Related]

  • 34. [Combination with SN-38 on human colon cancer LoVo cells].
    Wang Y, Xu JM, Xu QZ, Zhou PK, Song ST.
    Zhonghua Zhong Liu Za Zhi; 2009 Oct 05; 31(10):746-851. PubMed ID: 20021826
    [Abstract] [Full Text] [Related]

  • 35. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression.
    Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, Kung HF, Lai L, Jiang BH.
    PLoS One; 2011 Apr 22; 6(4):e19139. PubMed ID: 21544242
    [Abstract] [Full Text] [Related]

  • 36. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity.
    Yang H, Cheng R, Liu G, Zhong Q, Li C, Cai W, Yang Z, Ma J, Yang X, Gao G.
    Cancer Sci; 2009 Dec 22; 100(12):2419-25. PubMed ID: 19832843
    [Abstract] [Full Text] [Related]

  • 37. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.
    Zhang Y, Lu Y, Xu Y, Le Z, Liu Y, Tu W, Liu Y.
    Life Sci; 2023 May 15; 321():121594. PubMed ID: 36934971
    [Abstract] [Full Text] [Related]

  • 38. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
    Yafai Y, Lange J, Wiedemann P, Reichenbach A, Eichler W.
    Glia; 2007 Apr 15; 55(6):642-51. PubMed ID: 17309061
    [Abstract] [Full Text] [Related]

  • 39. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P, de Santa-María IS, Merlo A, Suarez C, Chiara MD.
    Head Neck; 2015 Aug 15; 37(8):1150-62. PubMed ID: 24798801
    [Abstract] [Full Text] [Related]

  • 40. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
    Hong B, Lui VW, Hui EP, Ng MH, Cheng SH, Sung FL, Tsang CM, Tsao SW, Chan AT.
    Invest New Drugs; 2011 Jun 15; 29(3):401-10. PubMed ID: 20013349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.